KR970032844A - Persistent Expenses - Google Patents
Persistent Expenses Download PDFInfo
- Publication number
- KR970032844A KR970032844A KR1019950066618A KR19950066618A KR970032844A KR 970032844 A KR970032844 A KR 970032844A KR 1019950066618 A KR1019950066618 A KR 1019950066618A KR 19950066618 A KR19950066618 A KR 19950066618A KR 970032844 A KR970032844 A KR 970032844A
- Authority
- KR
- South Korea
- Prior art keywords
- persistent
- agent
- dosing agent
- inflammatory agent
- dosing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
본 발명은 지속성 경비투여제제에 관한 것으로서 더욱 상세하게는 비스테로이드성 소염제, 흡수촉진제 및 점착성 폴리머를 함유하여 비강(鼻腔)을 통해 지속적으로 투여 흡수되는 지속성 경비투여제제 및 그 제조방법에 관한 것이다.The present invention relates to a persistent non-dosing agent, and more particularly, to a persistent non-dosing agent continuously containing and absorbing nonsteroidal anti-inflammatory agents, absorption accelerators and adhesive polymers through the nasal cavity, and a preparation method thereof.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
제1도는 본발명의 경비투여제제에 함유되는 비스테로이드성 소염제에 대한 점착성 폴리머의 함량비에 따른 용출율을 나타낸 그래프이고,1 is a graph showing the dissolution rate according to the content ratio of the adhesive polymer to the non-steroidal anti-inflammatory agent contained in the non-administration agent of the present invention,
제2도는 본 발명에서 제조한 경비투여제제의 시간 경과에 따른 용출율을 나타낸 그래프이고,2 is a graph showing the dissolution rate over time of the non-administration agent prepared in the present invention,
제3는 점착성 폴리머의 함유에 의한 시간 경과에 따른 약물 흡수율을 나타낸 그래프이다.Third is a graph showing the drug absorption rate over time due to the inclusion of the adhesive polymer.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950066618A KR970032844A (en) | 1995-12-29 | 1995-12-29 | Persistent Expenses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950066618A KR970032844A (en) | 1995-12-29 | 1995-12-29 | Persistent Expenses |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970032844A true KR970032844A (en) | 1997-07-22 |
Family
ID=66637382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950066618A KR970032844A (en) | 1995-12-29 | 1995-12-29 | Persistent Expenses |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970032844A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890003400A (en) * | 1987-08-03 | 1989-04-14 | 다까다 데츠오 | Bioactive Peptide Powder Composition (Formulation) for Nasal Administration |
US4983595A (en) * | 1986-05-22 | 1991-01-08 | Syntex (U.S.A.) Inc. | Aqueous steroid formulations for nasal administration |
WO1993025193A1 (en) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Pharmaceutical preparation for intra-airway administration |
KR950000770A (en) * | 1993-06-30 | 1995-01-03 | 이원강 | Dechlorinated deoxygenated resin composition and storage container using the same |
WO1995011042A1 (en) * | 1993-10-21 | 1995-04-27 | Hisamitsu Pharmaceutical Co., Inc. | Pernasal composition and pernasal preparation containing the same |
WO1995028158A1 (en) * | 1994-04-13 | 1995-10-26 | Janssen Pharmaceutica N.V. | Intranasal antimigraine composition |
-
1995
- 1995-12-29 KR KR1019950066618A patent/KR970032844A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4983595A (en) * | 1986-05-22 | 1991-01-08 | Syntex (U.S.A.) Inc. | Aqueous steroid formulations for nasal administration |
KR890003400A (en) * | 1987-08-03 | 1989-04-14 | 다까다 데츠오 | Bioactive Peptide Powder Composition (Formulation) for Nasal Administration |
WO1993025193A1 (en) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Pharmaceutical preparation for intra-airway administration |
KR950000770A (en) * | 1993-06-30 | 1995-01-03 | 이원강 | Dechlorinated deoxygenated resin composition and storage container using the same |
WO1995011042A1 (en) * | 1993-10-21 | 1995-04-27 | Hisamitsu Pharmaceutical Co., Inc. | Pernasal composition and pernasal preparation containing the same |
WO1995028158A1 (en) * | 1994-04-13 | 1995-10-26 | Janssen Pharmaceutica N.V. | Intranasal antimigraine composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880000088A (en) | Sustained release formulation | |
KR870000069A (en) | Process for preparing stable solid dosage forms | |
BR9609033A (en) | High viscosity controlled release system. | |
KR900002769A (en) | Long-acting sodium diclofenac preparations | |
GT199800126A (en) | COMBINATION THERAPY. | |
RS49803B (en) | Use of aqueous medicament prepara tions for the production of propellent gas-free aerosols | |
ES2190075T3 (en) | SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULFOALQUIL-ETER-CYCLODEXTRINE AND A THERAPEUTIC AGENT. | |
CO5070580A1 (en) | PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE SUBSTANCES | |
MX9301716A (en) | A PHARMACEUTICAL COMPOSITION THAT HAS A DEFINED LIPID SYSTEM. | |
BR9913742A (en) | Factor viia inhibitors | |
DE59609501D1 (en) | Crystal modification of the CDCH, process for its preparation and pharmaceutical preparations containing it | |
EA199900201A1 (en) | PHARMACEUTICAL AEROSOL COMPOSITION | |
KR930001896A (en) | Diclofenac Sodium Warning Agent | |
NO20000284L (en) | Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity | |
KR880701098A (en) | Methylprednisolone / sodium carboxymethyl starch tablet composition | |
MXPA97007996A (en) | Preparation for the transport of an active substance across barriers. | |
KR890007721A (en) | Chewable medicinal tablets comprising means for taste concealment | |
AR004168A1 (en) | PHARMACEUTICAL COMPOSITION LIQUID VERTIBLE AQUEOUS | |
KR970061246A (en) | Pharmaceutical Compositions for Increasing Testosterone | |
KR920021133A (en) | Warning | |
KR910007509A (en) | Injection composition for lipophilic pharmaceutical | |
KR970032844A (en) | Persistent Expenses | |
ATE237316T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IBUPROFEN AND DOMPERIDONE | |
KR880013557A (en) | New Ophthalmic Compositions | |
ATE254457T1 (en) | AQUEOUS LIQUID PHARMACEUTICAL COMPOSITION CONTAINING A BENZOPYRANE DERIVATIVE AS THE MAIN INGREDIENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |